![ASCO 2018 – wieder eine Menge an neuen Daten zum Lungenkarzinom - Onkologie - Universimed - Medizin im Fokus ASCO 2018 – wieder eine Menge an neuen Daten zum Lungenkarzinom - Onkologie - Universimed - Medizin im Fokus](https://www.universimed.com/custom/img/files/files_datafiles_data_Zeitungen_2018_Jatros_Onko_1805_Weblinks_jatros_onko_1805_s55_abb1.jpg)
ASCO 2018 – wieder eine Menge an neuen Daten zum Lungenkarzinom - Onkologie - Universimed - Medizin im Fokus
![Pembrolizumab + Chemotherapie beim NSCLC – gemeinsame Stellungnahmen von DGHO und AIO — Deutsche Gesellschaft für Hämatologie und med. Onkologie e.V. Pembrolizumab + Chemotherapie beim NSCLC – gemeinsame Stellungnahmen von DGHO und AIO — Deutsche Gesellschaft für Hämatologie und med. Onkologie e.V.](https://www.dgho.de/aktuelles/news/newsarchiv/2019/download-news-2019/pembro_tab1.jpg/@@images/1c789e1a-49a4-4545-a0b0-a23e440cd55b.jpeg)
Pembrolizumab + Chemotherapie beim NSCLC – gemeinsame Stellungnahmen von DGHO und AIO — Deutsche Gesellschaft für Hämatologie und med. Onkologie e.V.
![Frühe Nutzenbewertung - Atezolizumab Monotherapie beim nicht kleinzelligen Lungenkarzinom — Onkopedia Frühe Nutzenbewertung - Atezolizumab Monotherapie beim nicht kleinzelligen Lungenkarzinom — Onkopedia](https://www.onkopedia.com/de/news/atezolizumab-mono_nsclc.png/@@images/4362b760-b580-46e6-8f92-c13f8bdeea50.png)
Frühe Nutzenbewertung - Atezolizumab Monotherapie beim nicht kleinzelligen Lungenkarzinom — Onkopedia
![The therapeutic strategy for enrolled patients. Pem, pembrolizumab;... | Download Scientific Diagram The therapeutic strategy for enrolled patients. Pem, pembrolizumab;... | Download Scientific Diagram](https://www.researchgate.net/publication/359636562/figure/fig2/AS:1139880428093440@1648780080538/The-therapeutic-strategy-for-enrolled-patients-Pem-pembrolizumab-P-paclitaxel-C.png)
The therapeutic strategy for enrolled patients. Pem, pembrolizumab;... | Download Scientific Diagram
![Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 ... Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 ...](https://www.thelancet.com/cms/attachment/8683c32a-7f62-4423-b701-e7a9d5ff815c/gr1_lrg.gif)
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 ...
![Pembrolizumab + Chemotherapie beim NSCLC – gemeinsame Stellungnahmen von DGHO und AIO — Deutsche Gesellschaft für Hämatologie und med. Onkologie e.V. Pembrolizumab + Chemotherapie beim NSCLC – gemeinsame Stellungnahmen von DGHO und AIO — Deutsche Gesellschaft für Hämatologie und med. Onkologie e.V.](https://www.dgho.de/aktuelles/news/newsarchiv/2019/download-news-2019/pembro_tab2.jpg/@@images/aee9c2bb-c13b-478e-aaff-3a1487d9c8b3.jpeg)
Pembrolizumab + Chemotherapie beim NSCLC – gemeinsame Stellungnahmen von DGHO und AIO — Deutsche Gesellschaft für Hämatologie und med. Onkologie e.V.
![Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non–Small-Cell Lung Cancer | Journal of Clinical Oncology Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non–Small-Cell Lung Cancer | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.19.01348/asset/images/large/jco.19.01348f1.jpeg)
Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non–Small-Cell Lung Cancer | Journal of Clinical Oncology
![A Phase 2 Trial of Nab-paclitaxel in Combination With Anti-PD1 Therapy in Advanced Urothelial Cancer | Journal of Urology A Phase 2 Trial of Nab-paclitaxel in Combination With Anti-PD1 Therapy in Advanced Urothelial Cancer | Journal of Urology](https://www.auajournals.org/cms/asset/35b5daba-f8eb-4223-a067-337a5fd1f900/ju.0000000000002969fu1.gif)
A Phase 2 Trial of Nab-paclitaxel in Combination With Anti-PD1 Therapy in Advanced Urothelial Cancer | Journal of Urology
![ASCO 2020: Final Results of PEANUT: Pembrolizumab and Nanoparticle Albumin-Bound Paclitaxel as Salvage Therapy for Metastatic Urothelial Carcinoma ASCO 2020: Final Results of PEANUT: Pembrolizumab and Nanoparticle Albumin-Bound Paclitaxel as Salvage Therapy for Metastatic Urothelial Carcinoma](https://www.urotoday.com/images/PEANUT_trialdesign.png)
ASCO 2020: Final Results of PEANUT: Pembrolizumab and Nanoparticle Albumin-Bound Paclitaxel as Salvage Therapy for Metastatic Urothelial Carcinoma
![PDF] Health-Related Quality of Life With Carboplatin-Paclitaxel or nab- Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non-Small-Cell Lung Cancer. | Semantic Scholar PDF] Health-Related Quality of Life With Carboplatin-Paclitaxel or nab- Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non-Small-Cell Lung Cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/acec2f9f905b43201baf134e43badd22b9bd0153/4-Table1-1.png)
PDF] Health-Related Quality of Life With Carboplatin-Paclitaxel or nab- Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non-Small-Cell Lung Cancer. | Semantic Scholar
![A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer | npj Breast Cancer A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer | npj Breast Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41523-023-00541-2/MediaObjects/41523_2023_541_Fig1_HTML.png)
A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer | npj Breast Cancer
![A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013 | npj Breast Cancer A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013 | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-022-00500-3/MediaObjects/41523_2022_500_Fig1_HTML.png)
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013 | npj Breast Cancer
![Advanced/metastatic NSCLC treatment algorithm. All treatment options... | Download Scientific Diagram Advanced/metastatic NSCLC treatment algorithm. All treatment options... | Download Scientific Diagram](https://www.researchgate.net/publication/330924582/figure/fig1/AS:11431281213976390@1703255989925/Advanced-metastatic-NSCLC-treatment-algorithm-All-treatment-options-shown-may-be.jpg)
Advanced/metastatic NSCLC treatment algorithm. All treatment options... | Download Scientific Diagram
![A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non–Small Cell Lung Cancer Study: (NEJ048A/NEXUS) - ScienceDirect A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non–Small Cell Lung Cancer Study: (NEJ048A/NEXUS) - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525730423000104-gr1.jpg)